Greg Vistnes is speaking on the topic entitled, “The best use of evidence: the economist perspective.” This session brings together a group of leading economists to analyse the impact of economic evidence in merger cases and advise how to produce the best possible outcome.
For more information on this conference, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...